NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma

NCT07719634

Not Yet RecruitingNA

Sponsor: Assiut University

Conditions: Breast Fibroadenoma

Interventions: microwave ablation

assess the efficacy of MWA in reducing fibroadenoma volume and achieving complete lesion regression at 12 months post-treatment

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion criteria:

* Female participants ≥ 18 years
* Diagnosed with fibroadenoma by clinical and ultrasonographic signs, core needle biopsy done only if atypical fibroadenoma.
* Lesion(s) measurable by ultrasound (e.g., diameter 0.7 - 3.0 cm),distance from breast lesion to the skin and pectoralis muscle exceeding 10 mm and the lesion away from nipple areola area .
* Symptomatic lesion or patient preference for minimally invasive treatment

Exclusion criteria:

* Malignancy or high suspicion of malignancy, BIRADs 4 or more/if pathological proved.
* Active infection.
* Coagulopathy or contraindications to ablation.
* Distance from breast lesion to the skin and pectoralis muscle less than 10 mm and the lesion near nipple areola area .